Nuvalent
Nuvalent Logo
About Nuvalent
Nuvalent Inc is a clinical-stage biopharmaceutical company focused on developing precisely targeted therapies for patients with cancer. Leveraging expertise in chemistry and structure-based drug discovery, Nuvalent specializes in small molecule inhibitors designed to address resistance and selectivity challenges in oncogenic drivers. Its lead product candidates include NVL-520, a ROS1-selective inhibitor for ROS1-positive non-small cell lung cancer (NSCLC); NVL-655, an ALK-selective inhibitor for ALK-positive NSCLC; and NVL-330, a HER2-selective inhibitor for HER2-altered tumors. The company is headquartered in Cambridge, Massachusetts, and serves patients worldwide.
Address
One Broadway, 14th Floor
Cambridge, 02142
United States
Year founded
2017
Number of employees
100-200
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
